Realta Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$633K Buy
2,516
+192
+8% +$41.3K 0.2% 112
2026
Q1
$506K Sell
2,324
-230
-9% -$51K 0.18% 127
2025
Q4
$583K Buy
2,554
+189
+8% +$43.1K 0.19% 112
2025
Q3
$548K Sell
2,365
-2,720
-53% -$554K 0.18% 110
2025
Q2
$944K Sell
5,085
-549
-10% -$102K 0.37% 64
2025
Q1
$1.18M Buy
5,634
+180
+3% +$35K 0.54% 48
2024
Q4
$988K Sell
5,454
-1,239
-19% -$228K 0.41% 57
2024
Q3
$1.31M Sell
6,693
-2,814
-30% -$525K 0.6% 42
2024
Q2
$1.63M Buy
9,507
+347
+4% +$57.5K 0.32% 70
2024
Q1
$1.67M Sell
9,160
-456
-5% -$78.6K 0.34% 63
2023
Q4
$1.49M Sell
9,616
-611
-6% -$89.1K 0.34% 64
2023
Q3
$1.38M Sell
10,227
-2,852
-22% -$419K 0.32% 69
2023
Q2
$1.76M Sell
13,079
-431
-3% -$63.2K 0.39% 51
2023
Q1
$2.15M Buy
13,510
+91
+0.7% +$13.9K 0.52% 35
2022
Q4
$2.17M Buy
13,419
+616
+5% +$94.5K 0.53% 36
2022
Q3
$1.72M Buy
12,803
+535
+4% +$76.8K 0.45% 45
2022
Q2
$1.89M Sell
12,268
-518
-4% -$79.2K 0.46% 45
2022
Q1
$2.07M Buy
12,786
+1,763
+16% +$256K 0.41% 47
2021
Q4
$1.49M Buy
11,023
+285
+3% +$33.7K 0.33% 66
2021
Q3
$1.16M Buy
10,738
+490
+5% +$56K 0.27% 84
2021
Q2
$1.15M Sell
10,248
-345
-3% -$38.9K 0.27% 90
2021
Q1
$1.15M Buy
10,593
+689
+7% +$73.7K 0.3% 84
2020
Q4
$1.06M Buy
9,904
+173
+2% +$16.6K 0.3% 71
2020
Q3
$852K Sell
9,731
-2,380
-20% -$224K 0.29% 82
2020
Q2
$1.19M Buy
12,111
+1,373
+13% +$121K 0.39% 54
2020
Q1
$818K Buy
10,738
+99
+0.9% +$8.43K 0.35% 66
2019
Q4
$933K Buy
10,639
+917
+9% +$76.1K 0.26% 86
2019
Q3
$738K Buy
9,722
+1,746
+22% +$120K 0.2% 113
2019
Q2
$581K Sell
7,976
-822
-9% -$64.6K 0.16% 152
2019
Q1
$703K Buy
+8,798
New +$720K 0.32% 88

Other funds holding ABBV

Realta Investment Advisors's ABBV Position: Q2 2026 in Review

Realta Investment Advisors increased its AbbVie (ABBV) stake by 8.3% in Q2 2026, buying an estimated $41.3K and bringing the position to 2,516 shares worth $633K. The position accounts for 0.2% of the portfolio, ranked #112.

Realta Investment Advisors first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.17M in Q4 2022. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Realta Investment Advisors held 2,516 shares of AbbVie worth $633K as of Q2 2026.
  • Realta Investment Advisors bought 192 AbbVie shares in Q2 2026, an estimated $41.3K.
  • AbbVie made up 0.2% of Realta Investment Advisors's portfolio in Q2 2026, its #112 holding.
  • Realta Investment Advisors first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
  • Realta Investment Advisors's AbbVie position peaked at $2.17M in Q4 2022.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Realta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.